Integral Derivatives’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Integral Derivatives's PFE Position: Q4 2017 in Review
Integral Derivatives sold out of Pfizer (PFE) in Q4 2017, closing a stake of 34,299 shares — an estimated $1.17M sold.
Integral Derivatives first reported a position in PFE in Q1 2014 and held it in 9 quarters. The position peaked at $1.59M in Q2 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.
- Integral Derivatives reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
- Integral Derivatives sold 34,299 Pfizer shares in Q4 2017, an estimated $1.17M.
- Integral Derivatives first reported a position in Pfizer in Q1 2014 and held it in 9 quarters.
- Integral Derivatives's Pfizer position peaked at $1.59M in Q2 2017.
- 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.
Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.